Publications by authors named "Srdan Verstovsek"

100Publications

Novel Concepts of Treatment for Patients with Myelofibrosis and Related Neoplasms.

Cancers (Basel) 2020 Oct 9;12(10). Epub 2020 Oct 9.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12102891DOI Listing
October 2020

JAK Inhibition for the Treatment of Myelofibrosis: Limitations and Future Perspectives.

Hemasphere 2020 Aug 21;4(4):e424. Epub 2020 Jul 21.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000424DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375176PMC
August 2020

New Therapies in Development for Myelofibrosis.

Clin Lymphoma Myeloma Leuk 2020 Sep;20 Suppl 1:S69-S71

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2152-2650(20)30467-5DOI Listing
September 2020

Altered T-cell subset repertoire affects treatment outcome of patients with myelofibrosis.

Haematologica 2020 Jul 30. Epub 2020 Jul 30.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2020.249441DOI Listing
July 2020

Prognostic value of blasts in peripheral blood in myelofibrosis in the ruxolitinib era.

Cancer 2020 Jul 22. Epub 2020 Jul 22.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.33094DOI Listing
July 2020

Givinostat: an emerging treatment for polycythemia vera.

Expert Opin Investig Drugs 2020 Jun 21;29(6):525-536. Epub 2020 Jul 21.

Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2020.1761323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534842PMC
June 2020

Management of myelofibrosis after ruxolitinib failure.

Leuk Lymphoma 2020 08 16;61(8):1797-1809. Epub 2020 Apr 16.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1749606DOI Listing
August 2020

The Myelodepletive Phenotype in Myelofibrosis: Clinical Relevance and Therapeutic Implication.

Clin Lymphoma Myeloma Leuk 2020 Jul 26;20(7):415-421. Epub 2020 Feb 26.

Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.01.008DOI Listing
July 2020

Lymphocytic variant of hypereosinophilic syndrome: A report of seven cases from a single institution.

Cytometry B Clin Cytom 2020 Mar 11. Epub 2020 Mar 11.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21874DOI Listing
March 2020

Prevalence of pulmonary hypertension in myelofibrosis.

Ann Hematol 2020 Apr 19;99(4):781-789. Epub 2020 Feb 19.

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-03962-2DOI Listing
April 2020

Concurrent V617F and W515L in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.

Leuk Lymphoma 2020 04 21;61(4):963-966. Epub 2019 Nov 21.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1691202DOI Listing
April 2020

Mutational profiling in myelofibrosis: implications for management.

Int J Hematol 2020 Feb 19;111(2):192-199. Epub 2019 Oct 19.

Department of Leukemia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02758-zDOI Listing
February 2020

Novel treatment strategies for myeloproliferative neoplasms.

Rinsho Ketsueki 2019 ;60(9):1176-1185

Department of Leukemia, MD Anderson Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11406/rinketsu.60.1176DOI Listing
October 2019

Updates in the management of polycythemia vera and essential thrombocythemia.

Ther Adv Hematol 2019 30;10:2040620719870052. Epub 2019 Aug 30.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719870052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719465PMC
August 2019

Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors.

Curr Hematol Malig Rep 2019 10;14(5):460-468

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-019-00538-4
Publisher Site
http://dx.doi.org/10.1007/s11899-019-00538-4DOI Listing
October 2019

The Rationale for Immunotherapy in Myeloproliferative Neoplasms.

Curr Hematol Malig Rep 2019 08;14(4):310-327

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0428, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-019-00527-7DOI Listing
August 2019

The evolving understanding of prognosis in post-essential thrombocythemia myelofibrosis and post-polycythemia vera myelofibrosis vs primary myelofibrosis.

Clin Adv Hematol Oncol 2019 May;17(5):299-307

The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
May 2019

Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis.

Ann Hematol 2019 Jul 15;98(7):1611-1616. Epub 2019 May 15.

Section of Nephrology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1468, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03708-9DOI Listing
July 2019

Emerging drugs for essential thrombocythemia.

Expert Opin Emerg Drugs 2019 06 14;24(2):93-105. Epub 2019 May 14.

a MD Anderson Cancer Center , The University of Texas , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728214.2019.1615437DOI Listing
June 2019

SOHO State of the Art Updates and Next Questions: Myelofibrosis.

Clin Lymphoma Myeloma Leuk 2019 04 22;19(4):191-199. Epub 2019 Mar 22.

University of Michigan Rogel Cancer Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650193017
Publisher Site
http://dx.doi.org/10.1016/j.clml.2019.03.011DOI Listing
April 2019

SMAC mimetics as potential cancer therapeutics in myeloid malignancies.

Br J Haematol 2019 04 5;185(2):219-231. Epub 2019 Mar 5.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15829DOI Listing
April 2019

New Concepts of Treatment for Patients with Myelofibrosis.

Curr Treat Options Oncol 2019 01 24;20(1). Epub 2019 Jan 24.

Department of Leukemia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-019-0604-yDOI Listing
January 2019

Unique Case of Myeloproliferative Neoplasm with Two Rare Clonal Abnormalities: Rare JAK2 Exon 12 Mutation and Rare e14a3 (b3a3) BCR/ABL Fusion Transcript.

Acta Haematol 2019 21;141(1):23-27. Epub 2018 Nov 21.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000494427DOI Listing
September 2019

Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis.

Hum Pathol 2019 03 15;85:290-298. Epub 2018 Nov 15.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.10.026DOI Listing
March 2019

Therapeutic Approach to Young Patients With Low-Risk Essential Thrombocythemia: Primum Non Nocere.

J Clin Oncol 2018 Oct 22:JCO2018793497. Epub 2018 Oct 22.

Lucia Masarova and Srdan Verstovsek, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.79.3497
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.79.3497DOI Listing
October 2018

A multimodality work-up of patients with Hypereosinophilia.

Am J Hematol 2018 11 26;93(11):1337-1346. Epub 2018 Sep 26.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25247DOI Listing
November 2018

Pentraxin-3 plasma levels correlate with tumour burden and overall survival in patients with primary myelofibrosis.

Br J Haematol 2019 04 3;185(2):382-386. Epub 2018 Aug 3.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.15528
Publisher Site
http://dx.doi.org/10.1111/bjh.15528DOI Listing
April 2019

Patient Perceptions in Mast Cell Disorders.

Immunol Allergy Clin North Am 2018 08;38(3):505-525

Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Mastocytosis Center, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08898561183003
Publisher Site
http://dx.doi.org/10.1016/j.iac.2018.04.006DOI Listing
August 2018

Kit Mutations: New Insights and Diagnostic Value.

Immunol Allergy Clin North Am 2018 08 9;38(3):411-428. Epub 2018 Jun 9.

Leukemia Department, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 428, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.iac.2018.04.005DOI Listing
August 2018

Renal complications of primary myelofibrosis.

Leuk Lymphoma 2019 02 3;60(2):507-510. Epub 2018 Jul 3.

f Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1474525DOI Listing
February 2019

The co-occurrence of driver mutations in chronic myeloproliferative neoplasms.

Ann Hematol 2018 Nov 27;97(11):2071-2080. Epub 2018 Jun 27.

Department of Leukemia, UT MD Anderson Cancer Center, 1515 Holcombe Blvd (Unit 428), Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-018-3402-x
Publisher Site
http://dx.doi.org/10.1007/s00277-018-3402-xDOI Listing
November 2018

Management of Myelofibrosis-Related Cytopenias.

Curr Hematol Malig Rep 2018 06;13(3):164-172

Department of Leukemia, University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, FC4.3062, Unit 428, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-018-0447-9DOI Listing
June 2018

Highlights in myeloproliferative neoplasms from the 2017 American Society of Hematology Annual Meeting: commentary.

Authors:
Srdan Verstovsek

Clin Adv Hematol Oncol 2018 Feb;16 Suppl 4(2):20-23

The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
February 2018

Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure.

Clin Case Rep 2018 01 6;6(1):155-161. Epub 2017 Dec 6.

Department of Leukemia University of Texas MD Anderson Cancer Center Houston 77030 Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.1264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771935PMC
January 2018

Ruxolitinib for essential thrombocythemia?

Oncoscience 2017 Nov 1;4(11-12):148-149. Epub 2017 Nov 1.

Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncoscience.373DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769968PMC
November 2017

Therapy-related myelofibrosis does not appear to exist.

Blood Adv 2017 Jun 26;1(14):863-866. Epub 2017 May 26.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017007369DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737601PMC
June 2017

Bone marrow findings in blast phase of polycythemia vera.

Ann Hematol 2018 Mar 28;97(3):425-434. Epub 2017 Dec 28.

Department of Hematopathology, Unit 0072, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-3211-7DOI Listing
March 2018

SOHO State-of-the-Art Update and Next Questions: MPN.

Clin Lymphoma Myeloma Leuk 2018 01;18(1):1-12

Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.11.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915302PMC
January 2018

Sensitive PCR-based monitoring and early detection of relapsed JAK2 V617F myelofibrosis following transplantation.

Br J Haematol 2018 12 19;183(5):831-835. Epub 2017 Dec 19.

Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15059DOI Listing
December 2018

Targeting cistrome and dysregulated transcriptome of post-MPN sAML.

Oncotarget 2017 Nov 11;8(55):93301-93302. Epub 2017 Oct 11.

Kapil N. Bhalla: Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21752DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706789PMC
November 2017

Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.

Ann Hematol 2018 Jan 15;97(1):109-121. Epub 2017 Nov 15.

Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, 1400 Holcombe Blvd, Unit 428, PO Box 301439, Houston, TX, 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-3165-9DOI Listing
January 2018

JAK2 detection and allele burden measurement in saliva vs. peripheral blood in patients with myelofibrosis.

Leuk Res 2017 12 31;63:53-55. Epub 2017 Oct 31.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.10.016DOI Listing
December 2017